Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
FabRx Ltd, 3 Romney Road, Ashford, Kent, TN24 0RW, UK; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma Group (GI-1645), Universidade de Santiago de Compostela, 15782, Spain.
Drug Discov Today. 2021 Jan;26(1):69-79. doi: 10.1016/j.drudis.2020.10.021. Epub 2020 Oct 31.
Precision medicine is a field with huge potential for improving a patient's quality of life, wherein therapeutic drug monitoring (TDM) can provide actionable insights. More importantly, incorrect drug dose is a common contributor to medical errors. However, current TDM practice is time-consuming and expensive, and requires specialised technicians. One solution is to use electrochemical biosensors (ECBs), which are inexpensive, portable, and highly sensitive. In this review, we explore the potential for ECBs as a technology for on-demand drug monitoring, including microneedles, continuous monitoring, synthetic biorecognition elements, and multi-material electrodes. We also highlight emerging strategies to achieve continuous drug monitoring, and conclude by appraising recent developments and providing an outlook for the field.
精准医学在提高患者生活质量方面具有巨大的潜力,其中治疗药物监测(TDM)可以提供可行的见解。更重要的是,药物剂量不正确是医疗错误的常见原因。然而,目前的 TDM 实践既耗时又昂贵,并且需要专业技术人员。一种解决方案是使用电化学生物传感器(ECB),它价格低廉、便携且高度灵敏。在这篇综述中,我们探讨了 ECB 作为按需药物监测技术的潜力,包括微针、连续监测、合成生物识别元件和多材料电极。我们还强调了实现连续药物监测的新兴策略,并通过评估该领域的最新进展和展望来总结。